We are live on ! Find out more
DWA

Douglass Winthrop Advisors Portfolio holdings

AUM $5.46B
1-Year Est. Return 11.49%
This Fund
S&P 500
This Quarter Est. Return
+2.62%
1 Year Est. Return
+11.49%
3 Year Est. Return
+66.59%
5 Year Est. Return
+87.07%
10 Year Est. Return
+344%
AUM
$1.42B
AUM Growth
+$31.4M
Cap. Flow
+$956K
Cap. Flow %
0.07%
Top 10 Hldgs %
33.56%
Holding
253
New
27
Increased
65
Reduced
74
Closed
14

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$17.9M
2
DIS icon
Walt Disney
DIS
+$10.3M
3
MSFT icon
Microsoft
MSFT
+$8.1M
4
TIF
Tiffany & Co.
TIF
+$5.17M
5
BEN icon
Franklin Resources
BEN
+$3.51M

Sector Composition

Rank Sector Weight
1 Financials 18.45%
2 Consumer Staples 15.84%
3 Healthcare 15.25%
4 Industrials 12.92%
5 Technology 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHPG
151
DELISTED
Shire pic
SHPG
$520K 0.04%
+2,826
New +$510K
CTSH icon
152
Cognizant
CTSH
$21.5B
$498K 0.04%
8,700
-3,400
-28% -$205K
D icon
153
Dominion Energy
D
$62.5B
$493K 0.03%
6,325
NOC icon
154
Northrop Grumman
NOC
$77B
$489K 0.03%
2,200
PSX icon
155
Phillips 66
PSX
$82.9B
$463K 0.03%
5,831
-103
-2% -$8.41K
HAL icon
156
Halliburton
HAL
$27.9B
$461K 0.03%
10,170
APC
157
DELISTED
Anadarko Petroleum
APC
$459K 0.03%
8,623
-800
-8% -$40.5K
USB icon
158
US Bancorp
USB
$99.6B
$451K 0.03%
11,175
UBP
159
DELISTED
Urstadt Biddle Properties Inc.
UBP
$446K 0.03%
20,375
STI
160
DELISTED
SunTrust Banks, Inc.
STI
$431K 0.03%
10,500
OGE icon
161
OGE Energy
OGE
$10.3B
$430K 0.03%
13,140
PCYO icon
162
Pure Cycle
PCYO
$257M
$423K 0.03%
89,889
-4,000
-4% -$18.2K
SNY icon
163
Sanofi
SNY
$104B
$419K 0.03%
10,020
-5,000
-33% -$205K
CHTR icon
164
Charter Communications
CHTR
$14.7B
$411K 0.03%
+1,798
New +$386K
LH icon
165
Labcorp
LH
$24.3B
$406K 0.03%
3,632
BAX icon
166
Baxter International
BAX
$11.6B
$393K 0.03%
8,700
-11,315
-57% -$496K
MDT icon
167
Medtronic
MDT
$107B
$388K 0.03%
4,466
CRM icon
168
Salesforce
CRM
$134B
$379K 0.03%
4,770
+65
+1% +$5.1K
KHC icon
169
Kraft Heinz
KHC
$30.4B
$379K 0.03%
4,279
STZ icon
170
Constellation Brands
STZ
$22.2B
$376K 0.03%
2,275
ISRG icon
171
Intuitive Surgical
ISRG
$121B
$364K 0.03%
4,950
+900
+22% +$63.3K
ALE
172
DELISTED
Allete
ALE
$362K 0.03%
+5,600
New +$323K
TEVA icon
173
Teva Pharmaceuticals
TEVA
$35.9B
$362K 0.03%
7,200
ETR icon
174
Entergy
ETR
$54.1B
$358K 0.03%
+8,800
New +$338K
COF icon
175
Capital One
COF
$124B
$355K 0.03%
5,595

Similar funds

Douglass Winthrop Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, Douglass Winthrop Advisors held 253 positions worth $1.42B, up 2.3% from $1.39B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Douglass Winthrop Advisors's Q2 2016 filing shows 27 new, 65 increased, 74 reduced and 14 closed positions. Its largest new stake was MetLife: 29,704 shares worth $1.05M. The largest sale was Discovery, Inc. Series C Common Stock, an estimated $17.3M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Douglass Winthrop Advisors's largest Q2 2016 buy was MetLife: 29,704 shares worth $1.05M.
  • Douglass Winthrop Advisors added most to CVS Health in Q2 2016, an estimated $17.9M increase.
  • Douglass Winthrop Advisors's biggest Q2 2016 reduction was Discovery, Inc. Series C Common Stock, cutting an estimated $17.3M.
  • Douglass Winthrop Advisors fully exited Liberty Global Class C in Q2 2016, selling an estimated $9.41M.
  • Douglass Winthrop Advisors's ten largest holdings make up 34% of its $1.42B portfolio in Q2 2016.
  • Douglass Winthrop Advisors opened 27 new positions and closed 14 in Q2 2016.
  • Douglass Winthrop Advisors's portfolio value rose 2.3% quarter-over-quarter to $1.42B.

Based on Douglass Winthrop Advisors's 13F filing for Q2 2016, filed 13 Jul 2016.